1,160 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Bought by Algert Global LLC
Algert Global LLC purchased a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,160 shares of the medical research company’s stock, valued at approximately $214,000. Other hedge funds and other […]
Algert Global LLC purchased a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,160 shares of the medical research company’s stock, valued at approximately $214,000. Other hedge funds and other […]
